在白内障手术领域，新型人工晶状体（IOL）技术持续涌现，不断吸引着临床医生的关注。然而，新技术的普及往往伴随着审慎的观察与验证——医生们通常倾向于等待充足的疗效与安全性证据，才会将其纳入常规实践。本文基于2026年1月美国针对白内障手术医生的最新调研 ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

Please provide your email address to receive an email when new articles are posted on . MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the ...

双目植入Clareon Vivity IOLs微型单视设计，术后3个月评估双目未矫正及目标矫正视力，阅读性能接近正常，88%患者目标矫正近视 ...

(RTTNews) - Eye care firm Alcon Inc.(ALC) announced Tuesday that Vivity, an extended depth of focus or EDOF intraocular lens or IOL, is now available on the company's most advanced lens ...

Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...

FORT WORTH, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today new product launches in the U.S. as well as ...

Please provide your email address to receive an email when new articles are posted on . Advances in toric IOL technology and the option to correct presbyopia and astigmatism with the same lens have ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Intraocular Lens Market, Forecast by Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...